Fanconi Anemia

Fuatilia
Illustration of a Stanford researcher with briquilimab antibody vial in a lab, representing a new stem cell transplant method for Fanconi anemia.
Picha iliyoundwa na AI

Stanford antibody regimen enables stem cell transplants without radiation or busulfan in Fanconi anemia

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

A Stanford Medicine team reports that a single dose of the anti‑CD117 antibody briquilimab allowed three children with Fanconi anemia to undergo stem cell transplants without radiation or busulfan, achieving near‑complete donor cell engraftment in a phase 1b study published in Nature Medicine.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa